ConditionsBrainAgingCognitive AgingImmunosenescenceMental ProcessesMental DisordersNeurocognitive DisordersCognitionBrain DiseasesDementiaAlzheimer DiseaseMental HealthBehavioral SymptomsDepressionAnxiety
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55-80
SponsorUniversity Hospital, Bordeaux
About this trial
B cube is a new generation cohort to study the determinants and natural history of brain aging, using molecular epidemiology, in a representative sample (N=2000) of the general population from the age of 55 (the approximate age of onset of the first cognitive disorders and a target population particularly receptive to prevention messages). Special interest will be given to nutrition, a promising environmental exposure for prevention.
Eligibility criteria
Qualifiers
live in Bordeaux metropolitan area,
be between 55 and 80 years old (included),
selected in terms of socioeconomic level, according to a sampling strategy by age groups and income categories representative of the general population between 55 and 80 years of age
be affiliated with the social security system,
Disqualifiers
None
Trial design
Treatments tested in this trial
- Questionnaires
- Fasting blood sampling.
- Saliva collection and nasal or nasopharyngeal swab
- Urine and stool samples
- Hair and a tonenail (or hand nail) sampling
- Nasal microbiota
- Measurements
- Neuroimaging
- Medical visit
Treatment groups
2,050 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov